¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö : 2020-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö : 2020-09-03
±³À°ÀÏÀÚ : 2020-09-03
±³À°Àå¼Ò : Àü³²´ëÇб³º´¿ø ¸íÇд밭´ç  
±³À°ÁÖÁ¦ : 2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : È£³² Áöȸ  
´ã´çÀÚ : ±è⼺
¿¬¶ôó : 02-3486-8736  
À̸ÞÀÏ : laminion@hanmail.net      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09-03 ¸íÇд밭´ç 15:30~15:50 µî·Ï ¹× È£³²Áöȸ ȸÀå Àλ砠±è¼ö¿Ï(È£³²ÁöȸÀå) 
±âŸ 09-03 ¸íÇд밭´ç 15:50~16:00 ´ëÇѽÅÀåÇÐȸ ÀÌ»çÀå Àλ砠¾çö¿ì(´ëÇѽÅÀåÇÐȸ ÀÌ»çÀå) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 16:00~16:25 A severe case of tenofovir-associated acute kidney injury requring hemodialysis in a patient with chronic B hepatitis  Á¶¾Æ¿µ(ÀüÁÖ¿¹¼öº´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 16:25~16:50 Xanthogranulomatous osteomyelitis of chest wall in a kidney transplantation patient  ÃÖÁ¾ÀÎ(Á¶¼±´ëÇб³º´¿ø) 
Åä·Ð 09-03 ¸íÇд밭´ç 16:50~17:00 ÆгÎÅäÀÇ(ÁÖÁ¦: Interesting cases of kidney disease)  À̽Ä(ÀüºÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 17:00~17:25 ANCA associated vasculitides in a patient with positive serologic test for Hantan virus  ±èÇü¿Ï(ÀüºÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 17:25~17:50 A 2-year study on the combination therapy of angiotensin II receptor blocker and midrine for proteinuria reduction in patients with hypotension or normal blood pressure  °­Èñ¸²(¿ø±¤´ëÇб³º´¿ø) 
Åä·Ð 09-03 ¸íÇд밭´ç 17:50~18:00 ÆгÎÅäÀÇ(ÁÖÁ¦: Hot issues of management of kideny disease)  ¸¶¼º±Ç(Àü³²´ëÇб³º´¿ø) 
±âŸ 09-03 ¸íÇд밭´ç 18:00~18:10 Coffee Break & Photo  () 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 18:10~18:35 Impact of obesity on the quality of life in patients with CKD  ¼­»óÇå(Àü³²´ëÇб³º´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 18:35~19:00 God committee  À̱¤¿µ(ÀüÁÖ¿¹¼öº´¿ø) 
Åä·Ð 09-03 ¸íÇд밭´ç 19:00~19:10 ÆгÎÅäÀÇ(ÁÖÁ¦: Emerging problems of ethical conflict)  ¾È¼±È£(¿ø±¤´ëÇб³º´¿ø) 
±âŸ 09-03 ¸íÇд밭´ç 19:10~19:20 Æóȸ  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö : 2020-09-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀºÆò±¸ÀÇ»çȸ Á¦2Â÷¿¬¼ö±³À°(Àü¸³¼±ºñ´ëÁõ, °ú¹Î¼º¹æ±¤) : 2020-09-03
´ÙÀ½±Û ÇѾç´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú ¿Ü·¡¿¡¼­ ½ÃÇàÇÒ ¼ö ÀÖ´Â ºñ°ú °ü·Ã ÀçÈ° Ä¡·á : 2020-09-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
369 ´ë±¸ ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ´ë±¸¡¤°æºÏ ÁöºÎȸ Á¦2Â÷ ÇмúÁý´ãȸ : 2018-09-20 0 537 2018-08-08
368 °æ³² ´ëÇѼҾưúÇÐȸ °³Á¤µÈ °¡¿Í»çÅ°º´ Áø·áÁöħ¿Ü 1°Ç : 2018-09-20 0 778 2018-08-08
367 °­¿ø ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ °­¿øÁöȸ Áý´ãȸ : 2018-09-15 0 1,162 2018-08-08
366 °æ±â ±¹¸³¾Ï¼¾ÅÍ ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ǹ®´õ½Ê°úÁ¤ : 2018-09-15 0 578 2018-08-08
365 Àü³² Çѱ¹°£´ãÃé¿Ü°úÇÐȸ Á¦13Â÷ ±¹Á¦½Ì±ÛÅäÇȽÉÆ÷Áö¿ò : 2018-09-14 0 1,055 2018-08-08
364 ºÎ»ê ºÎ»ê¼Ò¾Æ°úÇÐȸ Á¤±â Çмú Áý´äȸ : 2018-09-13 0 1,484 2018-08-08
363 ´ë±¸ ´ëÇÑÄ¡¸ÅÇÐȸ ´ë±¸°æºÏÁöȸ 2018 Ãß°è ½ÉÆ÷Áö¿ò : 2018-09-13 0 459 2018-08-08
362 ÀüºÏ Á¦6ȸ ÀüºÏ´ëÇб³º´¿ø Áö¿ªÀǾàÇ°¾ÈÀü¼¾ÅÍ ½ÉÆ÷Áö¾ö : 2018-09-11 0 362 2018-08-08
361 ¼­¿ï ´ëÇѼҾư¨¿°ÇÐȸ Á¦17ȸ ¿¬¼ö°­Á : 2018-09-09 0 459 2018-08-08
360 ¼­¿ï ´ëÇÑÀçÈ°ÀÇÇаúÀÇ»çȸ 2018 Ãß°èÇмú´ëȸ : 2018-09-09 1 1,054 2018-08-08
359 ¼­¿ï 2018³âµµ ³úÆÄÁ¤µµ°ü¸®À§¿øȸ Á¤±â±³À° : 2018-09-09 0 667 2018-08-08
358 °æ³² Á¦1ȸ µ¿ºÎ°æ³²Çмú´ëȸ : 2018-09-08 0 851 2018-08-08
357 ¼­¿ï °æÈñ´ëÇб³º´¿ø ¹é¹ÝÁõ°ú »ö¼ÒÁúȯ : 2018-09-08 0 839 2018-08-08
356 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ Asthma School 2018 : 2018-09-08 0 374 2018-08-08
355 ¼­¿ï 2018³â ´ëÇѳëÀÎÀçÈ°ÀÇÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-08 0 406 2018-08-08
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷